CME: Offering mifepristone as an abortion option

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.